文献速递心外重症与机械循环支持先天性心脏病外科

儿童双心室辅助装置支持的应用与结局:倾向性评分匹配分析

Utilization and outcomes in biventricular assist device support in pediatrics.
PubMed 文献 · J Thorac Cardiovasc Surg · 2019-12-09

该研究基于Pedimacs注册数据,比较363例儿童中63例(17%)原发双心室辅助装置(BiVAD)与左心室辅助装置(LVAD)支持患者的结局,采用倾向性评分匹配减少患者异质性。匹配后6个月,BiVAD组与LVAD组移植率分别为52.5%与42.5%,存活带装置分别为32.5%与40%,死亡率分别为15%与10%;两组生存相似(P=.31),但BiVAD组大出血事件更多(P=.04)。结论认为未匹配的结局差异可能反映疾病严重程度而非支持模式。

要点

  • 匹配后BiVAD与LVAD儿童6个月生存相似(P=.31),但BiVAD出血事件更多(P=.04)。
  • 匹配后6个月BiVAD组移植52.5%、存活带装置32.5%、死亡15%。
  • 未匹配的结局差异可能反映疾病严重程度,而非装置选择本身。

核心结论

  • 倾向性评分匹配减少患者特征差异后,BiVAD与LVAD儿童生存无差异,但BiVAD组重大不良事件更多,尤其是出血。
  • 未匹配时LVAD与BiVAD队列的结局差异更可能反映疾病严重程度而非支持模式。

研究设计与样本

  • 回顾性队列研究,查询Pedimacs注册数据,纳入363例符合标准的儿童患者。
  • 63例(17%)接受原发BiVAD支持,其余接受LVAD支持;比较匹配前后两组结局。

主要发现

  • 匹配后6个月,BiVAD组(LVAD组)移植52.5%(42.5%)、存活带装置32.5%(40%)、死亡15%(10%)。
  • 两组生存相似(P=.31,log-rank),但BiVAD组出血重大不良事件更多(P=.04,log-rank)。
  • 植入后1周、1个月和3个月,两组机械通气、透析或胆红素升高比例相似。

临床怎么用

  • 儿童BiVAD支持时需警惕出血风险,加强出血监测与防治。
  • 装置选择应综合评估疾病严重程度,而非仅依据未匹配的结局差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with biventricular assist devices (BiVADs) have worse outcomes than those with left ventricular assist devices (LVADs). It is unclear whether these outcomes are due to device selection or patient factors. We used propensity score matching to reduce patient heterogeneity and compare outcomes in pediatric patients supported with BiVADs with a similar LVAD cohort. METHODS: The Pedimacs registry was queried for patients who were supported with BiVAD or LVAD. Patients were analyzed by BiVAD or LVAD at primary implant and the 2 groups were compared before and after using propensity score matching. RESULTS: Of 363 patients who met inclusion criteria, 63 (17%) underwent primary BiVAD support. After propensity score matching, differences between cohorts were reduced. Six months after implant, in the BiVAD cohort (LVAD cohort) 52.5% (42.5%) had been transplanted; 32.5% (40%) were alive with device, and 15% (10%) had died. Survival was similar between cohorts (P = .31, log-rank), but patients with BiVADs were more likely to experience a major adverse event in the form of bleeding (P = .04, log-rank). At 1 week and 1 and 3 months' postimplant, the percentage of patients on mechanical ventilation, on dialysis, or with elevated bilirubin was similar between the 2 groups. CONCLUSIONS: When propensity scores were used to reduce differences in patient characteristics, there were no differences in survival but more major adverse events in the patients with BiVADs, particularly bleeding. Differences in unmatched patient outcomes between LVAD and BiVAD cohorts likely represent differences in severity of illness rather than mode of support.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Baez Hernandez N, Kirk R, Sutcliffe D, et al. Utilization and outcomes in biventricular assist device support in pediatrics. J Thorac Cardiovasc Surg. 2019. PMID: 31948738. doi:10.1016/j.jtcvs.2019.11.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。